Imperial Clinical Research Services

02/27/2026

On Rare Disease Day, Imperial recognizes rare disease research for its important role within clinical development. Every study helps build the information needed to better understand conditions that affect fewer people but are no less significant.

We’re grateful to the participants who choose to take part in rare disease studies and to the study teams who work every day to advance this important research. Imperial is proud to support sponsors and CROs worldwide as they work to bring new options and new hope to those living with rare diseases.

02/20/2026

Imperial honors International Mother Language Day with a simple and essential truth: people understand best in their own language. That understanding shapes how confidently they navigate information, make decisions, and feel free to ask questions.

True representation in clinical trials means reaching the populations most impacted by the conditions under study. It begins with precise translation in the right languages and local dialects.This care helps preserve clarity and respect for every individual’s voice. We’re proud to support sponsors and CROs in their trials worldwide by helping make communication clear, accessible, and inclusive.

02/18/2026

AI technology combined with wearable devices is reshaping clinical trials and study endpoints. These devices use algorithms to analyze data, detect patterns and early risk, and generate insights in real time or near real time. But success takes more than deploying devices. Explore our latest blog for insights on how your next study can safely and effectively harness this potential: https://hubs.ly/Q043tjbd0.

Discover how wearables combined with AI are reshaping clinical trials, moving beyond site visits to participant-centric, real-world data.

02/14/2026

Happy ! Sending appreciation to the sponsors, CROs, and study teams who put their heart into everything they do, and who make our collaborations a pleasure.

02/11/2026

Imperial honors ; a time to recognize the contributions, experiences, and voices that have shaped, and continue to shape, the Black community. In clinical research, that recognition reinforces why representation matters—so new therapies reflect the people they are meant to treat.

We continue working with sponsors to strengthen diversity in clinical trials, including the creation of programs and communication tools that help reach and engage participants from underrepresented groups. When research includes the full range of lived experiences, the science is stronger, and the resulting therapies are more responsive to real-world needs.

02/06/2026

Imperial joins to highlight the impact cardiovascular disease has as the #1 killer in women and the persistent gaps women experience in awareness, diagnosis, and treatment. Through our global support of cardiac clinical trials, we provide study materials, logistics, and communication tools that help sites effectively reach, inform, and engage diverse women across all stages of participation. We honor the study participants and study teams whose commitment is driving the next generation of cardiovascular treatments.

02/06/2026

Interactive response technology/RTSM is no longer just a tool; it’s a strategic lever for modern clinical studies. At SCOPE 2026, Dan McDonald chaired a Logistics and Clinical Supply Track session, and a clear theme emerged: real progress in RTSM and clinical supply depends on smarter onboarding, thoughtful standards, stronger alignment, and a better site experience. The conversations showed how these pieces are converging and why today’s decisions will shape tomorrow’s capabilities.

Discussions showed how these elements are starting to come together—and how the choices we make today will directly influence tomorrow’s capabilities and study ex*****on.

Dan distills the key takeaways and outlines where the field is heading—and what it means for your clinical trials. Read the full blog here: https://hubs.la/Q0422R-k0.

Interactive response technology/RTSM has become a strategic lever in studies. Read our blog from sessions at SCOPE 2026 to discover more.

02/04/2026

On World Cancer Day, Imperial recognizes the global community striving to advance prevention, detection, and treatment. Cancer touches millions of lives every year, and that reality drives our work every day. We’re honored to support oncology studies worldwide, from ancillary supplies and equipment to patient- and site-facing print and digital materials, translations, and logistics. Our commitment is to provide sponsors and CROs with the resources needed to keep clinical trials moving smoothly and support participants at every step.

02/02/2026

We’re thrilled to be at ! Visit us at booth 1011 to connect with the Imperial team and see how we streamline site readiness and study start-up from end to end. From ancillary supplies, kitting, and equipment to study and site materials, printing, digital production, translations, and global fulfillment—we help sponsors and CROs reduce complexity and keep trials moving.

Learn more: https://hubs.la/Q040PHC00

01/29/2026

Are you heading to ? Let’s connect! Meet Hope and the Imperial team at booth 1011 to discover how we can simplify your next study. We offer a range of services, including ancillary supplies and equipment, kitting, clinical trial printing, writing, design, translation, patient engagement, warehousing, and global logistics.

By consolidating services that usually require five or more vendors, Imperial helps sponsors and CROs enhance continuity and control, leading to higher quality, faster timelines, and reduced overall study costs.

Email connect@imperialcrs.com to schedule a time with our team or learn more here: https://hubs.la/Q040PdP20.

01/27/2026

Deviations don’t just add extra work, they put your timelines, data integrity, and, most importantly, patient safety at risk. In our ongoing risk management series, we outline prevention-focused strategies to reduce deviations, including:
• Proactive risk assessment with cross-functional input
• Clear, role-based training tied to SOPs
• Monitoring systems that catch issues early
• Robust document control and version management
• Vendor qualification that aligns expectations from day one

At Imperial, we’ve seen that the most effective way to manage deviations is to build systems that help prevent them before they occur.

Explore the full post: https://hubs.la/Q040wvQh0

Learn how risk mitigation for clinical trial deviations helps protect data integrity, timelines, and patient safety.

01/26/2026

On , we recognize the important role customs teams have in clinical research. Every day, they oversee the movement of essential supplies destined for study sites around the globe, helping keep global studies supplied and moving.

Customs regulations directly influence the way clinical trial kits are prepared, documented, and shipped, shaping the strategies that keep global studies on schedule. Compliance is an Imperial specialty; learn how thoughtful kitting design supports smoother clearance and distribution: https://hubs.la/Q040kDpm0